Best of Neurodegenerative Diseases

This Best of Neurodegenerative Diseases brings you a selection of the latest and leading research published in our portfolio. We are highlighting the latest development in diagnosis, treatment, prevention and care of neurodegenerative diseases. This collection collates articles from multiple journals and topics as COVID-19, neuroinflammation, ageing, cognitive decline, molecular pathways of neurodegenerations and public health.

Best of Neurodegenerative Diseases

• SUMOylation in Neurodegenerative Diseases
  Andrea Princz; Nektarios Tavernarakis.
  Gerontology (2020) 66 (2): 122–130. (DOI:10.1159/000502142)

• Postoperative Cognitive Dysfunction and the Protective Effects of Enriched Environment: A Systematic Review
  Momin Hua; Jia Min
  Neurodegener Dis (2021) 20 (4): 113–122. (DOI:10.1159/000513196)
• Brain Atrophy Subtypes and the ATN Classification Scheme in Alzheimer’s Disease
  Nira Cedres; Urban Ekman; Konstantinos Poulakis; Sara Shams; Lena Cavallin; Sebastian Muehlboeck; Tobias Granberg; Lars-Olof Wahlund; Daniel Ferreira; Eric Westman; Alzheimer’s Disease Neuroimaging Initiative
  Neurodegener Dis (2021) 20 (4): 153–164. (DOI:10.1159/000515322)
• The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19
  Giulia Bommarito; Valentina Garibotto; Giovanni B Frisoni; Frédéric Assal; Patrice H Lalive; Gilles Allali
  Neurodegener Dis (2022) 22 (3-4): 91–103. (DOI:10.1159/000530566)
• Association between Gut Microbiota with Mild Cognitive Impairment and Alzheimer’s Disease in a Thai Population
  Pagakrong Wanapaisan; Mallika Chuansangeam; Saifon Nopnipa; Rubwad Mathuranyanon; Nutthawan Nonthabenjawan; Chanon Ngamsombat; Tanyaluck Thientunyakit; Weerasak Muangpaisan
  Neurodegener Dis (2022) 22 (2): 43–54. (DOI:10.1159/000526947)
• The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline
  Jeffrey D. Pyne; Adam M. Brickman
  Neurodegener Dis (2021) 21 (1-2): 1–23. (DOI:10.1159/000518581)
• Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson’s Disease and Atypical Parkinsonian Syndromes
  Michaela Kaiserova; Monika Chudackova; Hana Prikrylova Vranova; Katerina Mensikova; Anetta Kastelikova; David Stejskal; Petr Kanovsky
  Neurodegener Dis (2021) 21 (1-2): 30–35. (DOI:10.1159/000520302)
• Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson’s Disease
  Songzhe He; Shan Zhong; Gang Liu; Jun Yang
  Neurodegener Dis (2021) 20 (2-3): 55–64. (DOI:10.1159/000511083)

• Non-Pharmacological Treatments in Lewy Body Disease: A Systematic Review
  Lucia Guidi; Stefania Evangelisti; Andrea Siniscalco; Raffaele Lodi; Caterina Tonon; Micaela Mitolo
  Dement Geriatr Cogn Disord (2023) 52 (1): 16–31. (DOI:10.1159/000529256)
• Predicting Alzheimer’s Disease with Interpretable Machine Learning
  Maoni Jia; Yafei Wu; Chaoyi Xiang; Ya Fang
  Dement Geriatr Cogn Disord (2023) 52 (4): 249–257. (DOI:10.1159/000531819)
• The Link between APOE4 Presence and Neuropsychological Test Performance among Mexican Americans and Non-Hispanic Whites of the Multiethnic Health & Aging Brain Study – Health Disparities Cohort
  Sid E. O’Bryant; Robert C. Barber; Nicole Philips; Leigh A. Johnson; James R. Hall; Kumudu Subasinghe; Melissa Petersen; Arthur W. Toga; Kristine Yaffe; Robert A. Rissman; for the HABS-HD Study Team
  Dement Geriatr Cogn Disord (2022) 51 (1): 26–31. (DOI:10.1159/000521898)
• The Effect of Receiving a Diagnosis of Alzheimer’s Disease and Related Dementias on Social Relationships of Older Adults
  Takashi Amano; Addam Reynolds; Clara Scher; Yuane Jia
  Dement Geriatr Cogn Disord (2021) 50 (4): 401–406. (DOI:10.1159/000519581)
• Late-Life Depression, Cognitive Impairment, and Relationship with Alzheimer’s Disease
  Sandra Invernizzi; Isabelle Simoes Loureiro; Kendra G. Kandana Arachchige; Laurent Lefebvre
  Dement Geriatr Cogn Disord (2022) 50 (5): 414–424. (DOI:10.1159/000519453)
• Blunt Traumatic Brain Injury and Alzheimer Pathology
  Kurt A. Jellinger
  Dement Geriatr Cogn Disord (2022) 51 (5): 428–433. (DOI:10.1159/000527686)
• Pathobiological Subtypes of Alzheimer Disease
  Kurt A. Jellinger
  Dement Geriatr Cogn Disord (2021) 49 (4): 321–333. (DOI:10.1159/000508625)
• Physical Exercise Ameliorates the Cognitive Function and Attenuates the Neuroinflammation of Alzheimer’s Disease via miR-129–5p
  Zhen Li; Qi Chen; Jinxia Liu; Yifeng Du
  Dement Geriatr Cogn Disord (2020) 49 (2): 163–169. (DOI:10.1159/000507285)

• Exploring Shared Genetic Signatures of Alzheimer’s Disease and Multiple Sclerosis: A Bioinformatic Analysis Study
  Dasen Yuan; Bihui Huang; Meifeng Gu; Bang-e Qin; Zhihui Su; Kai Dai; Fu-hua Peng; Ying Jiang
  Eur Neurol (2023) 86 (6): 363–376. (DOI:10.1159/000533397)
• Prediction of Mild Cognitive Impairment Progression to Alzheimer’s Disease Based on Diffusion Tensor Imaging-Derived Diffusion Parameters: Construction and Validation of a Nomogram
  Xuefei Cheng; Dongxue Li; Jiaxuan Peng; Zhenyu Shu; Xiaowei Xing
  Eur Neurol (2023) 86 (6): 408–417. (DOI:10.1159/000534767)
• A 3-Gene-Based Diagnostic Signature in Alzheimer’s Disease
  Huimin Wang; Yanqiu Zhang; Chengyao Zheng; Songqi Yang; Xiuju Chen; Heng Wang; Sheng Gao
  Eur Neurol (2022) 85 (1): 6–13. (DOI:10.1159/000518727)
• Neurofilament Light Chain Levels Are Associated with Disease Activity Determined by No Evident Disease Activity in Multiple Sclerosis Patients
  Jarmila Szilasiová; Jaroslav Rosenberger; Miriam Fedičová; Pavol Mikula; Peter Urban; Zuzana Gdovinová; Marianna Vitková; Jozef Hanes; Eva Stevens
  Eur Neurol (2021) 84 (4): 272–279. (DOI:10.1159/000515806)
• The Potential of Neurofilament Light as a Biomarker in Alzheimer’s Disease
  Yong-lan Xiong; Tao Meng; Jing Luo; Hua Zhang
  Eur Neurol (2021) 84 (1): 6–15. (DOI:10.1159/000513008)

• Prevalence of Parkinson’s Disease in Adults Aged 65 Years and Older in China: A Multicenter Population-Based Survey
  Zhengyu Song; Shuai Liu; Xiyu Li; Meilin Zhang; Xiaodan Wang; Zhihong Shi; Yong Ji
  Neuroepidemiology (2022) 56 (1): 50–58. (DOI:10.1159/000520726)
• Association between Sleep and Alzheimer’s Disease: A Bibliometric Analysis from 2003 to 2022
  Ming Tang; Li Wu; Ziyi Shen; Junwen Chen; Yang Yang; Ming Zhang; Peilin Zhao; Guohui Jiang
  Neuroepidemiology (2023) 57 (6): 377–390. (DOI:10.1159/000533700)
• Burden of Parkinson Disease in China, 1990–2019: Findings from the 2019 Global Burden of Disease Study
  Zhilin Zheng; Zeyu Zhu; Chen Zhou; Lanxiao Cao; Guohua Zhao
  Neuroepidemiology (2023) 57 (1): 51–64. (DOI:10.1159/000527372)
• From Dementia to Eumentia: A New Approach to Dementia Prevention
  Vladimir Hachinski; Abolfazl Avan
  Neuroepidemiology (2022) 56 (3): 151–156. (DOI:10.1159/000525219)
• Descriptive Epidemiology of Neurodegenerative Diseases: What Are the Critical Questions?
  Giancarlo Logroscino; Daniele Urso; Rodolfo Savica
  Neuroepidemiology (2022) 56 (5): 309–318. (DOI:10.1159/000525639)
• Traumatic Brain Injury and Risk of Dementia and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
  Dongqing Gu; Shan Ou; Guodong Liu
  Neuroepidemiology (2022) 56 (1): 4–16. (DOI:10.1159/000520966)

• Differential Expression of miR-381-3p in Alzheimer’s Disease Patients and Its Role in Beta-Amyloid-Induced Neurotoxicity and Inflammation
  Meng Zhang; Yonglei Liu; Pingping Teng; Qing Yang
  Neuroimmunomodulation (2022) 29 (3): 211–219. (DOI:10.1159/000519780)
• Neurotensin-Binding Immunoglobulin G in Patients with Parkinson’s Disease
  Zamira M. Muruzheva; Daniil S. Egorov; Margarita T. Absalyamova; Dmitrii S. Traktirov; Marina N. Karpenko; Serguei O. Fetissov
  Neuroimmunomodulation (2023) 30 (1): 15–27. (DOI:10.1159/000527872)
• The Central Inflammatory Network: A Hypothalamic fMRI Study of Experimental Endotoxemia in Humans
  Natalia Färber; Jorge Manuel; Marcus May; Nilufar Foadi; Florian Beissner
  Neuroimmunomodulation (2022) 29 (3): 231–247. (DOI:10.1159/000519061)
• Integrated Proteomic and Phosphoproteomic Analysis of the Hippocampus in a Mouse Model of Early Life Inflammation
  Xin-miao Wu; Yu-zhu Gao; Ting-ting Zhu; Han-wen Gu; Jian-hua Tong; Jie Sun; Jian-jun Yang; Mu-huo Ji
  Neuroimmunomodulation (2023) 30 (1): 28–41. (DOI:10.1159/000527975)
• The Infected Lungs and Brain Interface in COVID-19: The Impact on Cognitive Function
  Larissa Joaquim; Amanda Della Giustina; Richard Simon Machado; Kiuanne Lino Lobo Metzker; Sandra Bonfante; Lucineia Gainski Danielski; Mariana Pereira de Souza Goldim; Fabricia Petronilho
  Neuroimmunomodulation (2022) 29 (4): 269–281. (DOI:10.1159/000526653)

Connect with Us

Contact Us

If you have any questions, just get in touch with the Editorial Office